Morgan Stanley
SLGC

Morgan Stanley’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Morgan Stanley’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,179,036
Closed -$18.2M – 8125
2023
Q4 		$18.2M Buy
7,179,036
+4,064,146
+130% +$9.46M ﹤0.01% 3433
2023
Q3 		$7.44M Buy
3,114,890
+1,133,874
+57% +$2.51M ﹤0.01% 3392
2023
Q2 		$4.58M Buy
1,981,016
+153,292
+8% +$433K ﹤0.01% 3842
2023
Q1 		$4.66M Buy
1,827,724
+47,146
+3% +$135K ﹤0.01% 3838
2022
Q4 		$4.47M Buy
1,780,578
+529,110
+42% +$1.48M ﹤0.01% 3848
2022
Q3 		$3.63M Buy
1,251,468
+100,024
+9% +$421K ﹤0.01% 3957
2022
Q2 		$5.21M Sell
1,151,444
-112,242
-9% -$668K ﹤0.01% 3715
2022
Q1 		$10.1M Sell
1,263,686
-425,590
-25% -$3.75M ﹤0.01% 2896
2021
Q4 		$19.7M Buy
1,689,276
+270,682
+19% +$3.24M ﹤0.01% 2161
2021
Q3 		$17.6M Buy
+1,418,594
New +$16M ﹤0.01% 2231

Morgan Stanley's SLGC Position: Q1 2024 in Review

Morgan Stanley sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 7,179,036 shares — an estimated $18.2M sold.

Morgan Stanley first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $19.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Morgan Stanley reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 7,179,036 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $18.2M.
  • Morgan Stanley first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Morgan Stanley's SomaLogic, Inc. Class A Common Stock position peaked at $19.7M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.